检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:史留斌[1] 宋宁[1] 芮晓晖[1] 张浩[1] 王乾伟[1] 石伟[1] 钱建民[1]
机构地区:[1]复旦大学附属华山医院器官移植科肝脏移植中心,上海200040
出 处:《中华实验外科杂志》2006年第2期230-232,共3页Chinese Journal of Experimental Surgery
摘 要:目的研究缺氧预适应对内皮细胞冷缺氧/温复氧损伤的作用及可能机制。方法培养的内皮细胞ECV-304分成4组,A组,对照组;B组,冷缺氧/温复氧(A/R)组95%N2/5%CO2缺氧装置中用4℃UW液保存24h;C组,缺氧预适应组(APC),内皮细胞在缺氧前遭受4个循环短时间缺氧/复氧;D组,缺氧诱导因子-1α(HIF-1α)抑制组缺氧预适应前,细胞培养液中加入5μmol/L的HIF-1α抑制剂NS398,余同C组。缺氧结束后,各组37℃5%CO295%空气中复氧6h。分别以逆转录-聚合酶链反应(RT-PCR)法、Western blot法检测各组HIF-1αmRNA和蛋白表达,内皮细胞保护作用通过细胞存活率(台盼蓝拒染法)、LDH释出率及ICAM-1的表达判定。结果缺氧预适应明显上调HIF-1αmRNA和蛋白表达,显著抑制冷保存内皮细胞缺氧/复氧损伤,表现为更高的细胞存活率,更少的LDH释出和ICAM-1的表达。而HIF-1α抑制剂可逆转这种保护作用。结论缺氧预适应能有效地抑制冷保存内皮细胞缺氧/复氧损伤,这种细胞保护作用可能是通过HIF-1α介导的。Objective To investigate the effect and mechanism of anoxia-preconditioning on cold anoxia/warm reoxygenation injury to endothelial cells. Methods Cultured endothelial cells were divided into 4 groups:Group A as control;Group B, the cells were preserved in 40℃ UW solution and subjected to 24 h-anoxia. Group C, hypoxia-preconditioning was performed by 4 cycles' short anoxia and reoxygenation before prolonged anoxia. Group D, pretreating the cells with HIF-1α inhibitor, NS398. After anoxia, the cells were exposed to 37℃ 5 96 CO2 95 96 air for 6 h. HIF-1αmRNA and protein expression was respectively determined by RT-PCR and Western blot. The cytoprotection was evaluated by Dyed rate of Typan blue, LDH release and ICAM-1 expression. Results Anoxia-preconditioning upregulated HIF-1α mRNA and augmented HIF-1α protein. The effect was accompanied by improved cell viability, reduced LDH release and ameliorated ICAM-1 expression. However, the effect was cancelled by NS398. Conclusion Anoxia-preconditioning can provide the protection to endothelial cell from cold hypoxia/ warm reoxygenation injury, and the effect may be mediated by HIF-1α.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.38